Oncology

All the posts published.

The workload at pCPA appears to have stabilized over 2019

November 14, 2019

-

Market Access News

-

Posted by MORSE

Read More →

Average Time Under pCPA Consideration Below 30 Days for the 3rd Consecutive Month

October 16, 2019

-

Market Access News

-

Posted by MORSE

Read More →

15 Oncology Files either Completed, Initiated or new Under Consideration

September 10, 2019

-

Market Access News

-

Posted by MORSE

Read More →

pCPA Closing More Negotiations Without Agreements

August 6, 2019

-

Market Access News

-

Posted by MORSE Team

Read More →

Number of Active Negotiations (49) at Highest Level Since November 2018

July 7, 2019

-

Market Access News

-

Posted by MORSE Team

Read More →

The pCPA Initiates Negotiations for a Second “Group” of Oncology Biosimilars

June 18, 2019

-

Market Access News

-

Posted by MORSE Team

Read More →

Has RWE in Canada Reached a Tipping Point?

October 23, 2018

-

Market Access News

-

Posted by Lorraine Boyle

Read More →

MORSE Consulting Proudly Participates at the 2018 CADTH Symposium

April 12, 2018

-

Market Access News, What's New

-

Posted by MORSE Team

Read More →

Introducing MORSE LINKS – A Comprehensive List of Pharmaceutical Market Access Resources

September 26, 2017

-

Market Access News, What's New

-

Posted by MORSE Team

Read More →

MORSE Consulting Inc.

Toronto | Ottawa, Canada

+1-647-717-3179 (Toronto)

+1-613-864-8645 (Ottawa)

info@morseconsulting.ca

MORSE Consulting Inc. | Deciphering Canadian pharmaceutical market access signals to create reimbursement success.

© 2021 MORSE Consulting Inc. All rights reserved. | Site by Directica Media

Oncology - Info and details on - Page 3 of 3 - MORSE Consulting Inc.